Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Tyra Biosciences, Inc. (TYRA) had Weighted-Average Shares Outstanding (Diluted) of 61.75M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-39.30M |
|
-- |
|
-- |
|
$42.00M |
|
$-42.00M |
|
$2.69M |
|
$-39.30M |
|
$-39.30M |
|
$-39.30M |
|
$-39.30M |
|
$-39.30M |
|
$-39.30M |
|
$-42.00M |
|
$-41.86M |
|
61.75M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
61.75M |
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$394.61M |
|
$1.22M |
|
$17.43M |
|
$412.04M |
|
$19.26M |
|
-- |
|
$5.21M |
|
$24.46M |
|
$387.57M |
|
$387.57M |
|
$387.57M |
|
59.47M |
|
| Cash Flow Statement Financials | |
$-32.57M |
|
$-120.24M |
|
$160.38M |
|
$78.39M |
|
$85.95M |
|
$7.57M |
|
$7.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.14% |
|
-10.14% |
|
-9.54% |
|
-10.14% |
|
$6.52 |
|
$-0.53 |
|
$-0.53 |
|